Case ReportNuclear Oncology
Somatostatin Receptor Expression in Hürthle Cell Cancer of the Thyroid
Seza A. Gulec, Aldo N. Serafini, Kasi S. Sridhar, Kamil R. Peker, Anurag Gupta, W. Jarrard Goodwin, George N. Sfakianakis and Frederick L. Moffat
Journal of Nuclear Medicine February 1998, 39 (2) 243-245;
Seza A. Gulec
Aldo N. Serafini
Kasi S. Sridhar
Kamil R. Peker
Anurag Gupta
W. Jarrard Goodwin
George N. Sfakianakis
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 39, Issue 2
February 1, 1998
Somatostatin Receptor Expression in Hürthle Cell Cancer of the Thyroid
Seza A. Gulec, Aldo N. Serafini, Kasi S. Sridhar, Kamil R. Peker, Anurag Gupta, W. Jarrard Goodwin, George N. Sfakianakis, Frederick L. Moffat
Journal of Nuclear Medicine Feb 1998, 39 (2) 243-245;
Jump to section
Related Articles
- No related articles found.
Cited By...
- 68Ga-DOTATOC PET/CT in Patients with Iodine- and 18F-FDG-Negative Differentiated Thyroid Carcinoma and Elevated Serum Thyroglobulin
- Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
- Diagnostic Accuracy and Prognostic Value of 18F-FDG PET in Hurthle Cell Thyroid Cancer Patients
- Peptide Receptor Imaging and Therapy